NOT KNOWN DETAILS ABOUT HEMGENIX

Amount of eligible individuals: CDEC reviewed the uncertainty in the volume of clients with reasonably serious to extreme hemophilia B in Canada qualified for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some individuals who're labeled as getting moderate or reasonable disorder could have a severe bleeding phenoty